David Hajjar

Q: What Schools Are Affiliated With David Hajjar

David Hajjar is affiliated with the following schools: University of Milan, University of Oxford, University of New Hampshire, Cornell University, Nankai University, Columbia University

David Hajjar's AcademicInfluence.com Rankings

David Hajjar

Engineering

#7615

World Rank

#9005

Historical Rank

#1343

USA Rank

Biomedical Engineering

#768

World Rank

#780

Historical Rank

#47

USA Rank

engineering Degrees

Download Badge

Engineering

David Hajjar's Degrees

PhD Biomedical Engineering Columbia University
Masters Biomedical Engineering Columbia University
Bachelors Biomedical Engineering Columbia University

Why Is David Hajjar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David P Hajjar is an American scientist, university administrator, and professor of pathology and biochemistry at Cornell University. He is best known for his work in arterial cholesterol trafficking.

(See a Problem?)

David Hajjar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. (2001) (1056)
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. (2000) (1012)
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* (1999) (806)
A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. (1997) (497)
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. (2000) (447)
A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* (2002) (371)
Inflammation in Atherosclerosis and Implications for Therapy (2004) (344)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
Redox regulation of cell signalling (1996) (301)
Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36* (1997) (293)
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. (1991) (274)
The Role of Phosphatidylinositol 3-Kinase in Vascular Endothelial Growth Factor Signaling* (1999) (246)
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. (2000) (245)
Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. (2000) (208)
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. (1981) (169)
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells (1987) (169)
Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells. (1982) (168)
Transforming Growth Factor-β1 (TGF-β1) and TGF-β2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-γ* (2000) (168)
Lipoprotein Trafficking in Vascular Cells (1997) (160)
Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. (1993) (151)
Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. (1986) (144)
Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases. (2013) (143)
Role of CD36, the Macrophage Class B Scavenger Receptor, in Atherosclerosis (2001) (140)
Inhibition of Macrophage Scavenger Receptor Activity by Tumor Necrosis Factor- Is Transcriptionally and Post-transcriptionally Regulated (*) (1996) (129)
Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network (1992) (129)
Inflammation at the molecular interface of atherogenesis: an anthropological journey. (2008) (126)
Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1. (1990) (123)
Vascular transcellular signaling. (1993) (120)
CD 36 : a class B scavenger receptor involved in angiogenesis , atherosclerosis , inflammation , and lipid metabolism (2001) (119)
Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells (1990) (115)
Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect. (1985) (113)
Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. (1989) (107)
Ligand Binding to Macrophage Scavenger Receptor-A Induces Urokinase-type Plasminogen Activator Expression by a Protein Kinase-dependent Signaling Pathway* (1998) (100)
Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. (1987) (100)
Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? (1998) (97)
Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. (1999) (96)
Arterial neutral cholesteryl esterase. A hormone-sensitive enzyme distinct from lysosomal cholesteryl esterase. (1983) (91)
Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury (1986) (90)
Metabolic activity of cholesteryl esters in aortic smooth muscle cells is altered by prostaglandins I2 and E2. (1983) (89)
Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. (1981) (87)
Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. (1991) (86)
Inhibition of ERK1/2 and Activation of Liver X Receptor Synergistically Induce Macrophage ABCA1 Expression and Cholesterol Efflux* (2009) (85)
Effector Cell Protease Receptor-1 Is a Vascular Receptor for Coagulation Factor Xa* (1996) (84)
NITRIC OXIDE ENHANCES PROSTAGLANDIN-H SYNTHASE-1 ACTIVITY BY A HEME-INDEPENDENT MECHANISM : EVIDENCE IMPLICATING NITROSOTHIOLS (1995) (83)
CD36 in Atherosclerosis: The Role of a Class B Macrophage Scavenger Receptor (2000) (83)
Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras. (2000) (82)
Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. (2008) (80)
Endothelium modifies the altered metabolism of the injured aortic wall. (1981) (78)
Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice (2015) (78)
Pitavastatin Downregulates Expression of the Macrophage Type B Scavenger Receptor, CD36 (2004) (76)
von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. (1993) (75)
Erratum: Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (Journal of Clinical Investigation (2000) 105 (1095-1108)) (2000) (69)
Recombinant Glutathione S-Transferase/CD36 Fusion Proteins Define an Oxidized Low Density Lipoprotein-binding Domain* (1998) (69)
Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression* (2012) (68)
Oxidized Low Density Lipoprotein Decreases Macrophage Expression of Scavenger Receptor B-I* (2001) (68)
Enhancement of cholesterol and cholesteryl ester accumulation in re-endothelialized aorta. (1980) (64)
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. (2002) (63)
CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis (2004) (61)
Identification of a monocyte receptor on herpesvirus-infected endothelial cells. (1991) (59)
Functional Interplay Between the Macrophage Scavenger Receptor Class B Type I and Pitavastatin (NK-104) (2004) (58)
Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue. (1990) (58)
Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. (1988) (57)
Prostaglandins and cyclic nucleotides. Modulators of arterial cholesterol metabolism. (1985) (56)
Regulation of prostaglandin H2 synthase activity by nitrogen oxides. (1999) (54)
Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase. (2013) (54)
Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. (1992) (54)
Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line Published, JLR Papers in Press, July 16, 2003. DOI 10.1194/jlr.M300084-JLR200 (2003) (52)
Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. (1991) (50)
Activation of peroxisome proliferator-activated receptor-α in mice induces expression of the hepatic low-density lipoprotein receptor (2008) (49)
Protein 3-nitrotyrosine in complex biological samples: quantification by high-pressure liquid chromatography/electrochemical detection and emergence of proteomic approaches for unbiased identification of modification sites. (2008) (48)
Mediation of virion penetration into vascular cells by association of basic fibroblast growth factor with herpes simplex virus type 1 (1990) (48)
Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression* (2012) (47)
Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation. (1994) (47)
Lipoprotein and albumin accumulation in reendothelialized and deendothelialized aorta. (1984) (47)
Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. (1993) (46)
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. (2006) (46)
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite Published, JLR Papers in Press, February 9, 2006. (2006) (45)
CD36, oxidized LDL and PPAR gamma: pathological interactions in macrophages and atherosclerosis. (2004) (44)
Anti‐adipogenic action of pitavastatin occurs through the coordinate regulation of PPARγ and Pref‐1 expression (2007) (44)
Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells. (1985) (43)
Interactions of arterial cells. Studies on the mechanisms of endothelial cell modulation of cholesterol metabolism in co-cultured smooth muscle cells. (1987) (43)
Diet-induced hypercholesterolemia inhibits the recovery of prostacyclin production by injured rabbit aorta. (1982) (40)
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. (2000) (40)
Tyrosine nitration in prostaglandin H(2) synthase. (2002) (38)
Regulation of neutral cholesteryl esterase in arterial smooth muscle cells: stimulation by agonists of adenylate cyclase and cyclic AMP-dependent protein kinase. (1986) (36)
Oxidative alterations of cyclooxygenase during atherogenesis. (2006) (35)
25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism[S] (2018) (35)
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. (2007) (35)
Atherosclerosis in LDLR-knockout mice is inhibited, but not reversed, by the PPARgamma ligand pioglitazone. (2009) (34)
Lipid accumulation and ultrastructural change within the aortic wall during early spontaneous atherogenesis. (1980) (33)
A Molecular Redox Switch on p21ras (1997) (33)
Genetic Deletion of Low Density Lipoprotein Receptor Impairs Sterol-induced Mouse Macrophage ABCA1 Expression (2008) (33)
Direct Observation of Nitrosylated Heme in Myoglobin and Hemoglobin by Electrospray Ionization Mass Spectrometry (1997) (33)
Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells. (2004) (31)
Oxygen tension within the arterial wall: relationship to altered bioenergetic metabolism and lipid accumulation. (1988) (30)
Induction of CD 36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-g (2000) (30)
Identification of interferon-γ as a new molecular target of liver X receptor. (2014) (30)
Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. (1993) (29)
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. (2010) (28)
Altered glycosaminoglycan metabolism in injured arterial wall. (1985) (28)
Tobacco constituents are mitogenic for arterial smooth-muscle cells. (1985) (28)
High-density-lipoprotein-induced cholesterol efflux from arterial smooth muscle cell derived foam cells: functional relationship of the cholesteryl ester cycle and eicosanoid biosynthesis. (1990) (27)
Transplantation of cryopreserved cultured epidermal allografts. (1996) (27)
Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products. (1989) (26)
Herpesviruses and thrombosis: activation of coagulation on the endothelium. (1999) (26)
Measuring Teaching: A Relative Value Scale in Teaching (1998) (26)
G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras. (1997) (26)
Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. (1994) (25)
Evidence for cytokine regulation of cholesterol metabolism in herpesvirus-infected arterial cells by the lipoxygenase pathway. (1990) (25)
Interaction of arterial cells. I. Endothelial cells alter cholesterol metabolism in co-cultured smooth muscle cells. (1985) (24)
Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. (1993) (22)
Herpesvirus infection prevents activation of cytoplasmic cholesteryl esterase in arterial smooth muscle cells. (1986) (21)
Platelet-neutrophil-smooth muscle cell interactions: lipoxygenase-derived mono- and dihydroxy acids activate cholesteryl ester hydrolysis by the cyclic AMP dependent protein kinase cascade. (1989) (21)
Signal transduction in atherosclerosis: second messengers and regulation of cellular cholesterol trafficking. (1995) (20)
Beta-VLDL increases endothelial cell plasma membrane cholesterol. (1991) (19)
Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. (2013) (19)
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. (2019) (19)
MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-An anti-atherogenic function of ERK1/2 inhibition. (2016) (18)
Human glial cell production of lipoxygenase-generated eicosanoids: a potential role in the pathophysiology of vascular changes following traumatic brain injury (1988) (18)
Cholesterol enrichment enhances expression of sterol-carrier protein-2: implications for its function in intracellular cholesterol trafficking. (1995) (18)
Prostaglandins modulate arterial cholesteryl ester metabolism. (1984) (16)
Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages. (2012) (16)
Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. (1989) (14)
Histidine-rich glycoprotein inhibits the antiproliferative effect of heparin on smooth muscle cells (1987) (14)
Viral activation of the coagulation cascade. (1999) (14)
Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice. (2011) (13)
Cholesterol metabolism is altered by hydrolytic metabolites of prostacyclin in arterial smooth muscle cells. (1986) (13)
Focal differences in bioenergetic metabolism of atherosclerosis-susceptible and -resistant pigeon aortas. (1980) (12)
Human glial cell production of lipoxygenase-generated eicosanoids: a potential role in the pathophysiology of vascular changes following traumatic brain injury. (1989) (12)
Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress. (2010) (12)
Oxidized lipoproteins and infectious agents: are they in collusion to accelerate atherogenesis? (2000) (10)
Pitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells. (2009) (10)
Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease. (2016) (10)
G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 2. Role of protein kinase C-delta in the regulation of eicosanoid production. (1997) (10)
Interactions between prostacyclin metabolism and cholesteryl ester metabolism in the vascular wall. (1983) (9)
Developmentally regulated herpesvirus plaque formation in arterial smooth muscle cells. (1993) (8)
Analysis of the physical state of cholesteryl esters in arterial-smooth-muscle-derived foam cells by differential scanning calorimetry. (1990) (8)
Rosiglitazone alleviates intrahepatic cholestasis induced by α‐naphthylisothiocyanate in mice: The role of circulating 15‐deoxy‐Δ12,14‐PGJ2 and Nogo (2020) (8)
Launching of an American Medical College in the Middle East: Educational Challenges in a Multicultural Environment (2013) (8)
Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis. (2016) (8)
Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages (2016) (7)
Viral Activation of Coagulation: Implications for Thrombosis and Atherosclerosis (1997) (7)
Cicletanine stimulates cholesteryl ester hydrolase activities and prostacyclin production in arterial smooth muscle cells. (1989) (6)
Rosiglitazone alleviates α-naphthylisothiocyanate-induced intrahepatic cholestasis in mice - The role of circulating 15d-PGJ2 and Nogo. (2019) (6)
Prostacyclin and cyclic nucleotides interact to modulate arterial cholesteryl ester metabolism. (1984) (6)
Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease. (2009) (6)
Leukotriene production by human glia. (1990) (6)
Role of eicosanoids and the cytokine network in transmembrane signaling in vascular cells. (1991) (6)
Eicosanoids and their role in atherosclerosis. (1989) (5)
Targeting CD36: Modulating inflammation and atherogenesis (2003) (5)
CD36, the Macrophage Class B Scavenger Receptor: Regulation and Role in Atherosclerosis (2001) (5)
International Partnerships for the Development of STEM and Medical Education of Middle Eastern Women (2019) (4)
Regulation of cholesteryl ester hydrolases. (1994) (3)
Complex “Cross Talk” Involving Nitric Oxide Metabolites: Who’s Listening? (2006) (3)
Reprint of "oxidative alterations of cyclooxygenase during atherogenesis" [Prostag. Oth. Lipid. M. 80 (2006) 1-14]. (2007) (3)
Modulation of arterial cholesteryl ester metabolism by prostacyclin and prostaglandin E2. (1985) (2)
Regulation of Peroxisome Proliferator-activated Receptor-γ-mediated Gene Expression (2002) (2)
TGF-β increases C-SIS mRNA in endothelial cells and stimulates the production of EC-derived mitogens for smooth muscle cells (1987) (2)
Viral genes and atherogenesis (1992) (2)
Molecular motions and thermotropic phase behavior of triacylglycerols and cholesteryl esters in herpesvirus-infected arterial smooth muscle cells: a deuterium nuclear magnetic resonance study. (1992) (2)
Arterial Endothelial Cell‐derived Eicosanoids Alter Cholesterol Metabolism in Arterial Smooth Muscle Cells (1988) (2)
Endothelial-smooth muscle cell interactions during atherosclerosis. (1986) (2)
Inflammatory Networks Linking Cardiovascular Disease, Diabetes, and Cancer (2017) (2)
Prospects for Policy Advances in Science and Technology in the Gulf Arab States: "The Role for International Partnerships". (2014) (2)
Role for Diplomacy in Advancing Global Science, Technology, Engineering, and Mathematics (STEM) Policies in the Twenty-First Century: (2015) (1)
International Partnerships for the Development of Science, Technology, Engineering, Mathematics, and Medical Education of Middle Eastern Women. (2020) (1)
Correlation of Morphological and Biochemical Components of Atherosclerotic Plaques (1983) (1)
U. S. Science Diplomacy as a Seed for the Advancement of Democracy in the near East (2015) (1)
Nanotechnology: Tools Microbiologists Can Use to Reﬁne Their Research and Become Nanobiologists (2016) (1)
Endothelium in Experimental Atherosclerosis (1980) (1)
BIOENERGETIC METABOLISM AND LIPID ACCUMULATION IN PIGEON ATHEROGENESIS (1978) (1)
Activation of PPARα and PPARγ induce expression of the hepatic LDL receptor (2007) (0)
De-endothelialized Rabbit Aorta CRITICAL ROLE OF NEOINTIMAL SMOOTH MUSCLE CELLS (1981) (0)
Homocyst(e)ine increase the functional expression of the macrophage receptor CD36 (2000) (0)
Biochemical Mechanisms Associated with the Lipolytic Effects of Calcium Channel Blockers (1993) (0)
Activation of PPAR{alpha} and PPAR{gamma} induce expression of the hepatic LDL receptor (2007) (0)
GeneticDeletionofLowDensityLipoproteinReceptorImpairs Sterol-inducedMouseMacrophageABCA1Expression (2008) (0)
Abstract: P670 THE HEME-HEME OXYGENASE PATHWAY MODULATES INFLAMMATORY EICOSANOID SYNTHESIS IN VASCULAR CELLS (2009) (0)
Isolation of Total RNA , Purification of Poly ( A ) RNA , and Northern Blotting (2004) (0)
4.P.306 Lipoproteins regulate expression of the class B macrophage scavenger receptor, CD36 (1997) (0)
Abstract: 987 NITRIC OXIDE DERIVATIVES, PROSTANOIDS, AND VASCULAR DISEASE (2009) (0)
BIOL 152-Inducible nitric oxide synthase contributes to biopterin oxidation and protein tyrosine nitration during atherogenesis (2008) (0)
Heme catalyzes tyrosine nitration and inactivation of cyclooxygenase‐1 by peroxynitrite (2006) (0)
Arterial Injury Alters Metabolism Of The Arterial Wall (1981) (0)
4P-0968 Pitavastatin down-regulates expression of the macrophages type B scavenger receptor, CD36 (2003) (0)
Genetic deletion of LDL receptor impairs mouse macrophage ABCA1 expression and cholesterol efflux: A new SREBP‐1 dependent mechanism (2007) (0)
Effects of different statins on insulin storage and secretion from pancreatic β-cells: mechanisms and clinical implications. (2019) (0)
Pioglitozone inhibits the progression, but does not reverse development of atherosclerosis, in LDL receptor‐deficient mice (2006) (0)
Diet-Induced Hyperc holesterolemia Inhibits the Recovery of Prostacyclin Production by Injured Ra bbit Aorta (2007) (0)
Inducible nitric oxide synthase contributes to MAPK‐phosphatase induction and abundance of cyclooxygenase‐2 expression in an inflammatory setting (2009) (0)
Role of Injury in Arterial Lipid Metabolism (1982) (0)
Elucidating the differential effects of statins on metabolism in pancreatic Β-cells cultured under high and low glucose (2022) (0)
Eicosanoids as regulatory lipids in smooth muscle cell function: implications for atherosclerosis (1990) (0)
Contribution of inducible nitric oxide synthase to protein tyrosine nitration and biopterin oxidation in ApoE‐null mice (2007) (0)
Tyrosine nitration in prostaglandin H2 synthase DOI 10.1194/jlr.M200199-JLR200 (2002) (0)
Offensives Against Vascular Injury Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways : Promising (2013) (0)
Inducible nitric oxide synthase mediates cyclooxygenase nitration and eicosanoid production (2006) (0)
We-W43:3 Activation of PPAR induces hepatic LDL receptor expression (2006) (0)
Herpesvirus infection of endothelial cells causes the release of PDGF and increases C-SIS mRNA (1987) (0)
The role of herpesviruses in atherogenesis (1999) (0)
Peroxynitrite modifications of cyclooxygenase‐1 are regulated by arachidonic acid (2007) (0)
Cytokine Regulation o Arterial Cholesterol Trafficking (1996) (0)
Arterial cell interactions: mechanistic studies related to eicosanoid and growth factor-induced alterations in cholesterol metabolism. (1988) (0)
Contents, Vol. 5, 1986 (1986) (0)
Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: Evaluation of E5324, an Acyl-CoA cholesterol acyltransferase inhibitor (1995) (0)
90 Cellular and molecular aspects of atherosclerosis: new and old theories (1997) (0)
Regulation of CD36 by PPARγ: Pro- or Antiatherogenic? (2002) (0)
Subject Index, Vol. 5, 1986 (1986) (0)

This paper list is powered by the following services:

Other Resources About David Hajjar

en.wikipedia.org

What Schools Are Affiliated With David Hajjar?

David Hajjar is affiliated with the following schools:

David Hajjar's Academic­Influence.com Rankings